Back to Journals » International Journal of Women's Health » Volume 17
A Qualitative Study of Fertility Preservation Experience in Women with Breast Cancer
Authors Wang Z , Yang X, Hong X, He Y , Xu A, Jiang X, Wei Q
Received 16 January 2025
Accepted for publication 10 April 2025
Published 23 April 2025 Volume 2025:17 Pages 1143—1155
DOI https://doi.org/10.2147/IJWH.S517901
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Vinay Kumar
Zilian Wang, Xinyi Yang, Xia Hong, Yu He, Aike Xu, Xuechun Jiang, Qun Wei
Reproductive Medicine Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, People’s Republic of China
Correspondence: Qun Wei, Reproductive Medicine Center, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 Qingchun East Road, Hangzhou, Zhejiang, 310020, People’s Republic of China, Email [email protected]
Objective: To explore the experiences of women with breast cancer who have undergone fertility preservation and to explore the psychological needs of patients.
Methods: Using descriptive phenomenological research methods, 11 patients who underwent oocyte or embryo cryopreservation after diagnosis of breast cancer were selected for semi-structured interviews in a tertiary care hospital. Themes were distilled using Colaizzi’s 7-step analysis and reported according to COREQ guidelines.
Results: The experiences of women with breast cancer who underwent fertility preservation can be categorized into 4 themes and 11 sub-themes: a. Physical pain and discomfort (physiological pain, tolerance of physical discomfort); b. heavy psychological burdens (fertility worries, self-blame and guilt, loneliness and helplessness, bias from others and self); c. Actively seeking and benefiting from ways of coping with illness (life over procreation; hope, confidence and courage; positive coping with illness; adequate social support; growth follow in adversity); d. Lack of fertility-related information support.
Conclusion: Oncology and reproductive health professionals should pay attention to the experiences of breast cancer patients undergoing fertility preservation and target timely, scientific, and effective interventions to promote disease recovery and improve quality of life.
Keywords: breast cancer, tumor, fertility preservation, assisted reproductive technology, qualitative research
Introduction
Breast cancer represents the most common form of malignant tumor in women of childbearing age. In China, there is an incidence of approximately 357,000 new cases of breast cancer on an annual basis, constituting 7.4% of all cancer cases. Survey data demonstrate that up to 40% of women of reproductive age who have survived breast cancer express a desire to have children.1–4
It is important to note that both the disease itself and the anti-cancer treatment can have a detrimental effect on a woman’s fertility. Chemotherapy and radiotherapy have been shown to have a direct impact on gonadal function, and the reproductive age that is delayed as a consequence of the fight against cancer is accompanied by a natural decline in ovarian function.5,6 The advent of fertility preservation techniques, including oocyte and embryo cryopreservation, has enabled women of childbearing age diagnosed with breast cancer to realize their fertility aspirations.7,8 However, women diagnosed with breast cancer who are undergoing fertility preservation treatment face the dual stress of undergoing antitumor therapy for breast cancer and the implementation of fertility preservation techniques. In addition to the physical discomfort associated with ovarian stimulation and oocyte retrieval surgery, and the emotional distress caused by endocrine hormone changes, there is also the risk of cancerous cells spreading due to delays in oncological treatments, and the potential for breast cancer to recur as a consequence of pregnancy.9 An in-depth understanding of the experiences and needs of women with breast cancer of reproductive age during treatment is necessary to ensure successful implementation of fertility preservation therapy.10
At present, qualitative research into the experiences of women with breast cancer undergoing fertility preservation treatment is limited to the need for fertility preservation decision-making.11,12 Women’s experiences of fertility preservation influenced by socio-cultural differences.13 Therefore, this study adopted the descriptive phenomenological research method in qualitative research to interview breast cancer fertility preservation patients, with the aim of gaining an in-depth understanding of the physical and psychological experiences of women with breast cancer during fertility preservation treatment in the context of Chinese culture, and to provide a reference base for clinical health care to develop targeted intervention strategies.
Methods
Study Design
The study was guided by descriptive phenomenological research methods in qualitative research, using face-to-face semi-structured interviews to collect data, and reporting according to COREQ guidelines.14 Descriptive phenomenology is centered on the idea of “returning to the thing itself”, and emphasizes the pure experience or “primitive intuition” of the individual in relation to phenomena. It advocates the release of the individual from traditional concepts, theories, prejudices and customary ways of thinking, and the recognition of things from the pure phenomena that are initially perceived, with the ultimate objective being the realization and grasp of the essence of facts and their meanings.15 The two interviewers had learned and mastered the content and interviewing techniques of qualitative research. The first author, the primary interviewer, has been working in reproductive health for over ten years and is a clinically experienced co-chief superintendent nurse. The other interviewer was a postgraduate nursing student who assisted with the transcription and analysis of the interviews. The interviewers were all women with no experience of fertility preservation or breast cancer to minimize personal bias; the interviewer was involved in the daily care of the interviewees and developed a full relationship of trust with the interviewees.
Ethics Approval
This study strictly followed the Declaration of Helsinki and was approved by the Medical Ethics Committee of Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (Approval ID: 2024-0572). All participants gave informed consent and volunteered to participate in this study. Personal information was anonymized and only members of the research team had access to the audio recordings and transcripts. Participants could withdraw at any time during the study with no consequences.
Participants
A purposive sampling method was used to select women with breast cancer who underwent fertility preservation from July 2024 to October 2024 at the Reproductive Centre of a tertiary-level hospital in Hangzhou city as the study population. Data were obtained from the hospital’s electronic medical record system, and patients who underwent fertility preservation after diagnosis of breast cancer were selected by the researcher. Multidimensional sampling was conducted to exclude external factors from biasing the results, and participants with different ages, education levels, marital status, and different fertility preservation methods were purposely approached. The purpose and significance of the study were explained to them and face-to-face interviews were conducted after obtaining informed consent.
Inclusion Criteria
- Women aged 18 to 42;
- Patients with breast cancer confirmed by pathological examination or biopsy;
- Patients with basic Mandarin listening and speaking skills, normal understanding and expression skills, and no communication barriers;
- Patients undergoing fertility preservation therapy who have a desire to have children or need to reproduce;
- Patients voluntarily participated in the study and obtained informed consent.
Exclusion Criteria
- Patients with severe cognitive impairment or a history of mental illness;
- Patients with serious diseases of other systemic systems.
Withdrawal Criteria
- Patients voluntarily withdrew from the study;
- The investigator concluded that the patient was medically unfit for further participation in the study.
Sample
The sample size was determined based on the saturation of information, that is, when no new content emerged from the interview data. A total of 17 potential participants were approached in this study, among whom 2 participated in the pre-interviews, and 4 refused to join due to their unwillingness to self-disclose. Finally, 11 patients who underwent fertility preservation after breast cancer treatment were formally interviewed, including 6 cases of oocyte cryopreservation and 5 cases of embryo cryopreservation. Their ages ranged from 22 to 43 (31.09 ± 6.88) years old. The interview data were coded with Arabic numerals, and the general information of the research subjects was presented in Table 1.
![]() |
Table 1 General Information of Interviewees (n=11) |
Procedure
Development of the Interview Guide
Prior to the formal interview, the research team conducted a discussion through literature review combined with clinical experience, according to the research purpose, and formulated a preliminary interview outline. 2 team members (1 associate chief nurse and 1 master nurse) conducted a preliminary interview with one breast cancer patient undergoing embryo cryopreservation and another undergoing oocyte cryopreservation. According to the interview results, the research team discussed and revised the interview outline as follows.
- When you had breast cancer and learned that breast cancer treatment could affect fertility, how did you feel about fertility?
- How do you obtain information about fertility preservation?
- How do you feel during fertility preservation treatment?
- What difficulties did you encounter during fertility preservation treatment, and how did you cope with them?
- What support do you desire during fertility preservation treatment?
Data Collection
The interview was conducted in a quiet, private room with comfortable environment and seats to ensure that the interview process would not be disturbed and the confidentiality of the information would be protected. Prior to the interview, the interviewees agreed and signed informed consent. The interview process was conducted according to the interview outline, and the whole process was recorded. During the interview, the interviewees were encouraged to fully express their real experiences and feelings, listen carefully to their stories, and give feedback and follow-up in real time. Avoid induction and suggestion, observe and record the non-verbal behaviors of the interviewees, such as facial expressions, body language, voice tone, etc. The duration of each interview was determined by the respondents’ answers. The shortest time was 35 min, the longest was 55 min, and the average interview time was 41 min.
Data Analysis
Data collection and data analysis were carried out simultaneously. After each interview, the researcher will transcribe the recording into text verbatim within 24 hours, record the non-verbal information during the interview, and verify any doubts with the interviewer in time. The text data were imported into NVivo 12.0 software, and Colaizzi 7-step analysis method was used to analyze the data jointly by two researchers:16,17
- Read all interview materials carefully to get a holistic view;
- Extract meaningful statements that are consistent with the research phenomenon;
- Generalize and refine ideas from meaningful statements;
- Seek common concepts or characteristics of ideas to form themes;
- Relate the topic to the research object and describe the phenomenon completely;
- State the essential structure that constitutes the phenomenon;
- Return the results to the research object, verify the authenticity of the content, and integrate new data into the phenomenon description during the process.
During the data analysis process, the true insider’s perspective is captured and presented, the richness is mined and presented as much as possible rather than superficially, every research decision is reflected upon, a reflective journal is written and a critical evaluation is made. At the end of the data analysis, the group conducts a re-listen session to correct and review the initial analysis of the text to ensure the accuracy and precision of the data.
Result
Physical Pain and Discomfort
Physiological Pain
Most patients reported increased sensitivity to painful stimuli after the diagnosis of breast cancer, with somatic pain brought on by the overlap of dual treatment for breast cancer and fertility preservation.
N2: After I got sick, I had less sex, and the pain and discomfort of the transvaginal ultrasound to monitor follicular development was pretty bad.
N10: (With tears in her eyes), I get nervous easily and follicle monitoring for vaginal ultrasound always uncontrollably raises my bum, which the doctor says adds to the pain during the test.
N4: In the past 2 weeks, I’ve gone through breast cancer surgery, the post-surgery scar pain hasn’t subsided, and I’m dealing with oocyte retrieval operation!
N11: Injections hurt! I’ve been afraid of needles since I was a kid, and now I have to have ovulation injections every day, blood tests for hormones two to three days apart, and have to deal with all kinds of needles.
Tolerance of Physical Discomfort
Some patients reported that ovulation induction treatment for fertility preservation caused physical discomfort such as breast swelling, abdominal bloating and frequent urination.
N7: I’ve got a bit of a bloated stomach and I find it hard to breathe when I’m lying down. I find a cushion or a thick quilt on my back helps with the discomfort.
N9: Today is the 10th day of ovulation injections, and my stomach is as bloated as a big carp that is about to spawn!. (Laughs bitterly)
N11: I’ve got stomach cramps, nausea, no appetite.
N5: I always feel like I have to pee really badly, but when I go, I only pee a little bit.
N6: I felt swelling and pain in my breasts, and the doctor said it was related to the elevated hormones from the ovulation medication injections.
Heavy Psychological Burdens
Fertility Worries
The conundrum of fertility and survival presents patients with a challenging decision, necessitating a delicate balancing act between pursuing fertility preservation therapy and undergoing breast cancer treatment. Patients express a sense of apprehension regarding the unpredictability of breast cancer prognosis in the context of fertility preservation, while some individuals harbor significant concerns pertaining to fertility.
N1: I’ve got hormone-sensitive breast cancer, and I’ve had fertility preservation treatments. These might make my breast cancer grow faster, and there’s a chance it could come back during pregnancy.
N3: While I was having the injections, my breasts were really swollen and painful, so I was worried the cancer was spreading quickly, and I couldn’t sleep at night.
N6: I’m worried that treatment for my breast cancer will damage my ovaries, and I’m really sad at the thought of not being able to have children in the future.
N1: I’ve frozen my eggs, but I’m still not sure who would want to marry a girl like me who is physically handicapped and may not be able to have children.
N9: I’m worried that breast cancer might affect my intimacy with my husband. I’ve had a chat with my doctor about freezing some of my eggs. I’m going to have a few of them frozen and then paired with embryos, so that if I get divorced, at least I’ll have some eggs that belong to me.
Self-Blame and Guilt
The financial burden of anti-cancer and fertility preservation treatments can be significant, often requiring additional care and support from family members. Some patients perceive the challenges faced by their family members as a result of their own treatment as a source of familial stress, leading to feelings of self-blame.
N2: My family is worried about my illness. I’m feeling really down.
N6: I don’t know what I did in my past life to cause this problem and drag my family into it. (sighs)
N8: I quit my job because of my oncology treatment, and now I’m dependent on my parents for money. Although some of the cost of fertility preservation treatments can be put towards my health insurance, it’s still very stressful.
For traditional Chinese families, pregnancy and childbirth is the expectation of the whole family, and women bear the responsibility of bearing offspring. In instances where childbirth becomes challenging, patients may experience feelings of guilt under the pressure exerted by their families and themselves. Breast cancer is a hereditary disease that runs in families, and offspring are also at risk of developing the disease. Some patients experience feelings of guilt due to concerns about transmitting the disease to their offspring.
N9: I might also pass my cancer genes on to my children, I don’t want to think that the next generation might have to suffer the same pain I did. (weeping)
N5: My husband has been there for me through my breast cancer treatment, and I’d feel guilty if I couldn’t make his dream of becoming a dad a reality.
N4: My daughter is eight and all her classmates have brothers or sisters. She’d really like one too, but unfortunately, I can’t have children. I’m really sorry about that.
Loneliness and Helplessness
During treatment, divorced or unmarried patients lack the support and companionship of their partners. Some patients are afraid that their family and friends will worry and are reluctant to seek help from them. The lack of opportunities to talk and share their feelings makes some patients feel lonely. The inevitable exposure of the breasts and perineum during treatment also makes patients feel helpless.
N6: I’m divorced and single, and people show up in pairs, so I’m left alone in the waiting area.
N8: It’s not good to talk to friends about things like this (fertility preservation), but I also don’t want my parents to worry, so I go to the hospital on my own each time.
N4: I’m often feel exhausted and don’t have anywhere to talk about it.
N10: I feel uncomfortable and helpless about exposing the privacy of my body for breast cancer treatment and fertility preservation treatment.
N11: The unpleasant experience of having to expose the upper half of my body for breast treatment exams and the lower half of my body naked for fertility preservation treatments was something I had to deal with yet many times!
Bias from Others and Self
The patient suffers from altered self-image, and after radical mastectomy for breast cancer, the patient finds it difficult to adjust to the missing breast. Patients described trying to cover up as much as possible by matching clothing and avoiding seeing the mutilated body in the mirror, as patients lacked a sense of self-identity. Some patients described being looked at differently when sharing their experiences with others, not being understood, and enduring prejudice from others and self.
N5: While I was waiting for my consultation, some patients looked at me differently when they found out about my condition. They said things like, ‘You are risking your life! Why don’t you start the breast cancer treatment quickly, come here (to the fertility department) and fool around, you’re really not afraid of death!
N7: She stroked her lower abdomen and then pointed to her forehead, saying, I don’t dare to look in the mirror, and during this time of ovulation stimulation injections, my stomach has risen to such a large size, and one side of my breasts is flat, so I’m just a weirdo.
N8: One of my breasts is gone, and no matter how much attention I pay to my dress code, I can’t hide the flaws in my femininity.
Actively Seeking and Benefiting from Ways of Coping with Illness
Life Over Procreation
The value of life is paramount, and the process of cancer treatment can have a significant impact on fertility. However, some patients have reported that, when making decisions regarding fertility preservation treatment, they prioritize survival over fertility, placing their own lives above the preservation of their fertility.
N2: In the face of this diagnosis, I prioritized my own well-being, opting for a surgical excision of the tumor and subsequent egg freezing.
N3: My lover says that losing a life makes ideals vain and that controlling the growth of a tumor is more important than wanting a child.
Hope, Confidence and Courage
Women with breast cancer who underwent fertility preservation treatment generally expressed that, despite the uncertainty they faced, the treatment offered a perspective on a possible future, including the possibility of becoming mothers. Despite the difficulties and challenges, some of the patients expressed hope and anticipation for the future, which was crucial for their psychological adjustment and allowed them to demonstrate strength, courage and confidence in the future.
N7: The road ahead won’t be easy, but this treatment has given me hope. I feel like my future is full of possibilities!
N8: Gaze ahead (with a vision for the future) and say, I am still young, the cure rate for breast cancer is not low, and I want to get married normally, start a family and have children of my own.
N2: I told my husband I’d fight for the children.
N9: Fertility preservation therapy gives me a sense of continuity in life.
N4: My fellow patients say that the egg retrieval process is the hardest part, but I’m not worried about it. It’s definitely worth the effort to have a child.
N9: Maybe in the future I won’t need to use frozen eggs, I’ve discussed with my lover that I will try to conceive naturally when the disease is under control, after all I’m still young. (confident)
Positive Coping with Illness
Some patients have been observed to possess a more positive understanding of their own understanding of life and living, and are able to maintain an optimistic mindset, better face the challenges of treatment and life, and adopt a healthier diet and lifestyle to positively cope with their illnesses during the course of treatment.
N3: I never went to bed after midnight, but now I’m in bed by 10 p.m. every night.
N5: I’ll make sure to schedule some outdoor time every day.
N2: I get bombarded with diet, nutrition and health info on social media because that’s what I’m interested in.
N9: My family and I don’t usually order takeaways anymore, it’s safer and healthier to make our own food!
N6: I don’t drink milk tea and coffee anymore, but I used to drink them every day.
N4: It’s really important to listen to your doctor, get plenty of exercise, cooperate with treatment, and follow the required review and physical examinations.
Adequate Social Support
Some patients reported experiencing a sense of profound emotional support from their family, friends, and medical staff during the treatment process. This support was identified as a significant factor in their ability to maintain a positive attitude. Furthermore, the development of social connections among patients undergoing fertility preservation treatment has been observed, with some patients establishing friendships with others in similar circumstances. These peer relationships have been noted to provide a supportive network for patients to share their experiences and emotions.
N1: The mutual support of my fellow patients makes me feel like I’m not alone in my battle.
N6: While I was waiting for my consultation, I met a sister who had the same disease as me and both of us had to have fertility preservation. We became good friends and encouraged each other.
N3: After I got sick, my mother-in-law followed the doctor’s advice on nutrition and made different kinds of food to suit my taste.
N4: It’s really comforting to know that so many people care about me and have my back. It gives me the strength to face my treatment with courage.
N9: For now, my husband’s cancelled all his social commitments so he can be with me.
N11: I’m not alone, my family, friends, and doctors are fighting alongside me on many levels.
N5: The doctors are actively helping me, and I am confident about the future.
Growth Follows in Adversity
Some patients reported experiencing personal growth from having to re-examine their lives in the face of the challenges of breast cancer and fertility preservation treatments, as well as discovering their own strength and resilience in the face of adversity.
N1: This tough experience has made me realize that I’m strong, taught me how to deal with problems and appreciate what I’ve got.
N11: You know what? I was afraid of needles when I was a child, but now I can learn to inject myself with medication for fertility preservation treatments.
In the face of the fragility of life, many patients initiate a process of reflection on the aspects of life that are of true importance, such as family, friendships and personal happiness. In order to cope with the emotional turmoil associated with the treatment process, many patients have been observed to learn to express their feelings and needs more effectively. The benefits of this include a reduction in psychological burden and an improvement in communication skills, as well as the promotion of healthier relationships.
N9: I am now focusing on healthy living and spending more time with family and friends.
N11: I’m willing to pour my thoughts out to my family and friends, and that’s a good feeling.
Lack of Fertility-Related Information Support
Lack of support for fertility information from specialists during the consultation process. After diagnosis, when faced with decisions about breast cancer treatment and fertility preservation treatment, most patients want to obtain timely expertise on disease treatment and fertility preservation treatment from breast specialists and reproductive healthcare professionals to facilitate a quick decision-making process for fertility preservation. Due to the uneven distribution of healthcare resources, not all hospitals are equipped to provide fertility preservation treatments, and some patients are unable to receive information and support on fertility preservation during their visits.
N1: Medical information resources are not the same everywhere, and my doctor at the local hospital did not suggest preserving my fertility.
N2: I want healthcare professionals to explain why fertility preservation is important using some examples. This will help me to decide as soon as possible.
N4: I didn’t realize the consequences of breast cancer treatment on fertility issues until I accidentally swiped the information from the ‘Little Red Book’. (an APP)
N8: I had already received one radiotherapy treatment before I realized the importance of fertility preservation and then came to the fertility department for consultation.
In addition, some patients also want policy support.
N7: I am worried that pregnancy may cause a relapse or aggravate my condition, and I hope that I can solve my fertility problem through surrogate motherhood.
Discussion
Enhancing Pain Management in Women with Breast Cancer Undergoing Fertility Preservation
This study posits that women diagnosed with breast cancer encounter acute pain during the diagnostic process, treatment modalities, and fertility preservation therapy. The pain is primarily attributed to surgical incisions, transvaginal ultrasounds, the improper use of speculums, ovulation induction injections, and frequent blood draws for hormonal variable monitoring.18 In addition to various invasive procedures, the presence of muscle tightness and avoidance behaviors, which are often the result of excessive patient tension, has been demonstrated to exacerbate pain during treatment. Research has demonstrated that the perineal vestibular area is more sensitive in breast cancer patients than in the general population, resulting in them experiencing more severe painful stimuli.19 In addition to pain perception, somatic complaints associated with ovulation induction therapy have been reported during fertility preservation in breast cancer patients, including chest distension, abdominal bloating and urinary frequency, which have been associated with changes in hormone levels and compression caused by the increased size of the ovaries after ovulation induction therapy.20 Pain and physical discomfort not only affect the patient’s physical state, but may also affect his/her psychological and emotional well-being, creating fear and avoidance of treatment and ultimately affecting the success of the pregnancy.21,22 Effective pain management should be practiced in nursing practice to reduce somatic discomfort and improve the overall patient experience of care.23
Focus on the Psychological Complexities of Women with Breast Cancer Undergoing Fertility Preservation
This study highlights the complex psychological experiences of women with breast cancer during fertility preservation treatment, which include profound anxiety and restlessness, feelings of self-blame and guilt, feelings of loneliness and helplessness, and biases from the self-versus the community, in line with Ghaemi et al.24 The paradox of reproductive decision-making is the most important challenge faced by breast cancer patients. The dilemma of choosing between cancer treatment and fertility preservation leads to a state of anxiety, fear and anxiety, which can lead to insomnia and a constant state of anxiety in daily life, creating a vicious circle that can increase the physical burden.25 In addition to fear, feelings of loneliness and helplessness are not uncommon among women with breast cancer. Lack of family support, expensive treatment, genetic risk of the disease, exposure of body and privacy due to fertility preservation treatments, and changes in self-image during cancer treatment place a great psychological burden on the patient.26–28 The traditional Chinese concept of fertility is that women have the task of bearing children and carrying on the family line, and that the issue of fertility is not only a personal issue, but also a reflection of the needs of the family and the responsibilities assigned to women by society.29 Some breast cancer patients feel guilty and blame themselves for having children, especially in rural or religiously influenced areas where traditional attitudes are strong, and family and social prejudices can lead to exploitation and abuse with even more serious consequences.30,31 Therefore, how to enable patients to correctly understand the disease and alleviate their adverse emotions is the key focus for healthcare professionals to pay attention to. At different stages of cancer treatment and rehabilitation, patients’ different needs and changes in psychological status related to childbirth should be continuously assessed, and individualized and precise support should be given to patients to alleviate their worries, satisfy their emotional needs and realize their social values.32,33
Enhancement of Positive Coping Skills of Women with Breast Cancer Undergoing Fertility Preservation
The results of the study showed that women with breast cancer experienced post-traumatic growth during fertility preservation treatments, not only demonstrating strength and confidence in fighting the disease, but also producing positive behavioral changes, consistent with An et al.11 This behavioral change may be related to psychological resilience, and research has shown that higher psychological resilience improves an individual’s ability to adapt in trauma, and that increased psychological resilience reduces psychological stress, improves treatment adherence, and produces positive coping,34 for example, dietary changes, regular work schedules, increased physical activity, etc., to support treatment outcomes and improve quality of life.35 Some patients expressed optimism and hope for the future as they underwent treatment, believing that even in the shadow of cancer, they could create possible happiness for themselves and their families.4 However, some studies suggest that breast cancer patients have relatively low levels of psychological resilience and that disease recovery and quality of life can be facilitated by improving disease cognition, physical activity, and strengthening family and social support,36,37 which is consistent with the findings of this study. Deep social support, post-traumatic growth and hope for the future have been the driving force behind their coping and perseverance in treatment.38 Healthcare professionals should value the role of these positive psychological experiences and help patients better cope with the treatment process by providing comprehensive care and support. Improving patients’ knowledge of the disease, implementing personalized psychological guidance, providing peer communication, strengthening family support, improving psychological resilience, and promoting patients to face the disease with a positive mindset.36,39
Strengthening Information Support for Women with Breast Cancer Receiving Fertility Preservation
This study suggests that women with breast cancer lack access to resources and channels for professional information, decision support and policy help in fertility preservation treatments, consistent with Chen et al.40 The lack of professional guidance and the uneven distribution of healthcare resources have resulted in unmet needs for reproductive decision-making among breast cancer patients, who are able to seek out available resources on their own, yet the information they obtain on their own is very heterogeneous, unreliable and of poor quality, and therefore requires specialized expertise.41 Patients need more direct professional guidance and decision support for complex treatment choices in order to help them assess the pros and cons of various treatment options and reduce uncertainty.37 To meet the needs of patients, healthcare providers need to strengthen interdisciplinary cooperation and training to bridge the information gap. At the same time, multidisciplinary teams should be established to provide personalized counselling and case studies to help understand the importance of fertility preservation.42,43 In addition, some patients would like to receive support at the policy level, such as surrogacy and other flexible reproductive choices. Healthcare professionals should actively explain the boundaries of assisted reproductive technology and provide more diversified reproductive choices to meet the treatment needs of patients and to safeguard their psychological and physiological health.44 At present, online applications, teleconferencing software and communication software are used in disease prevention, screening and diagnosis, remote check-ups and post-discharge family support in breast cancer and assisted reproduction treatment, and a decision support system that enriches professional online information support is one of the avenues that can be explored.45
Conclusion
In this study, semi-structured interviews were conducted with 11 female patients undergoing fertility preservation treatment for breast cancer, and the results suggest that this group suffers from pain and somatic discomfort, heavy and complex psychological burdens, and unmet supportive care needs during fertility preservation treatment, and that the majority of the patients are able to positively seek out ways to cope with their illness and benefit from them. Professionals need to provide multifaceted support to women undergoing fertility preservation treatment for breast cancer, including pain management, psychological support, positive lifestyle adjustments, reinforcement of positive psychological experiences, and identification and fulfillment of unmet care needs, in order to improve patients’ quality of life and treatment experience.
Patient Consent
After explaining the purpose and content of the study to the patients, informed consent for this study was obtained from the patients and the paper version of the informed consent form was signed. All patients have given consent for publication of anonymous responses and direct quotes. All patient information in the study will be anonymized to eliminate the risk of disclosure.
Acknowledgments
We are grateful for everyone involved in this study.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Funding
This research is funded by the Zhejiang Province Traditional Chinese Medicine Science and Technology Project (Grant No. 2024ZF100, 2024KY112).
Disclosure
The authors declare that there is no potential conflict of interest for this work.
References
1. Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708–1728. doi:10.1016/j.cell.2023.01.040
2. Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20(8):417–436. doi:10.1038/s41568-020-0266-x
3. Wang Q, Zhao P, Zhang H, Guo Y. Advances in fertility information needs and supportive intervention strategies for breast cancer patients of childbearing age. Chin J Nurs Educ. 2023;20(10):1266–1270.
4. Koizumi T, Sugishita Y, Suzuki-Takahashi Y, et al. Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: randomized controlled trial. Cancer. 2023;129(16):2568–2580. doi:10.1002/cncr.34796
5. Chemerinski A, Cameron K, Sammel M, Ginsberg J, Carlson C, Gracia C. Relationship of menopausal symptoms and ovarian reserve in reproductive-aged cancer survivors. J Cancer Survivorship. 2020;14(5):607–613. doi:10.1007/s11764-020-00857-z
6. Wang B, Li Y. Treatment and ethical consideration of fertility preservation in young breast cancer patients. Chin Medl Ethics. 2021;34(01):88–92.
7. Wang Z, Zhu H, Tong X, Jiang L, Wei Q, Zhang S. Clinical outcomes after elective double-embryo transfer in frozen cycles for women of advanced maternal age: a retrospective cohort study. Medicine. 2022;101(9):e28992. doi:10.1097/md.0000000000028992
8. Xu W, Zhu H, Tong X, Zhang S. Clinical application of vitrification and freezing of oocytes. Nat Med J China. 2020;100(18):1409–1413. doi:10.3760/cma.j.cn112137-20191108-02424
9. Letourneau JM, Wald K, Sinha N, et al. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer. 2020;126(3):487–495. doi:10.1002/cncr.32546
10. Mulder RL, Font-Gonzalez A, Hudson MM, et al. Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22(2):e45–e56. doi:10.1016/s1470-2045(20)30594-5
11. An P, Wang H, Wu K, Ding Y. Inner experience of fertility preservation decision in young women with early breast cancer. Chin Nurs Manage. 2022;22(03):354–358.
12. Sun M, Liu C, Zhang P, et al. Perspectives and needs for fertility preservation decision-making in childbearing-age patients with breast cancer: a qualitative study. Asia Pac J Oncol Nurs. 2024;11(8):100548. doi:10.1016/j.apjon.2024.100548
13. Ying L, Wu LH, Loke AY. The effects of psychosocial interventions on the mental health, pregnancy rates, and marital function of infertile couples undergoing in vitro fertilization: a systematic review. J Assist Reprod Genet. 2016;33(6):689–701. doi:10.1007/s10815-016-0690-8
14. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi:10.1093/intqhc/mzm042
15. Sundler AJ, Lindberg E, Nilsson C, Palmér L. Qualitative thematic analysis based on descriptive phenomenology. Nurs Open. 2019;6(3):733–739. doi:10.1002/nop2.275
16. Faraji A, Jalali A, Khatony A, Jalali R. Exploring nurses’ experiences of recommended patient care: a descriptive phenomenological study. BMC nurs. 2024;23(1):61. doi:10.1186/s12912-024-01736-z
17. Wang Y, Xu Y, Tang X, Chen X, Pan H. A qualitative study of psychological experience in patients waiting for re-kidney transplantation. Chin J Nurs Educ. 2023;58(18):2189–2194.
18. Yanik F, Tokat MA. Sleep quality, perceived stress and associated factors in women undergoing IVF treatment: short-term longitudinal study. J Reprod Infant Psychol. 2024;8:1–16. doi:10.1080/02646838.2024.2339481
19. Goetsch MF, Lim JY, Caughey AB. Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. Obstet Gynecol. 2014;123(6):1231–1236. doi:10.1097/aog.0000000000000283
20. Gomaa S, Lopez A, Slamon R, et al. The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation. Support Care Cancer. 2023;31(12):719. doi:10.1007/s00520-023-08170-y
21. Saravelos SH, Wong AW, Kong GW, Huang J, Klitzman R, Li TC. Pain during embryo transfer is independently associated with clinical pregnancy in fresh/frozen assisted reproductive technology cycles. J Obstet Gynaecol Res. 2016;42(6):684–693. doi:10.1111/jog.12962
22. Eid M, Lemoine A, Bardet L, et al. Pain after oocyte retrieval in women with endometriosis undergoing fertility preservation or IVF. Reprod Biomed Online. 2024;49(3):104100. doi:10.1016/j.rbmo.2024.104100
23. Haenen V, Dams L, Meeus M, De Groef A. Altered somatosensory functioning and mechanism-based classification in breast cancer patients with persistent pain. Anat Rec. 2024;307(2):273–284. doi:10.1002/ar.25121
24. Ghaemi SZ, Keshavarz Z, Tahmasebi S, Akrami M, Heydari ST. Conflicts women with breast cancer face with: a qualitative study. J Family Med Prim Care. 2019;8(1):27–36. doi:10.4103/jfmpc.jfmpc_272_18
25. Roberson PNE, Tasman JG, Woods SB, Cortez G, Somers TJ, Lloyd J. Overcoming patient pain together: breast cancer patients and caregivers’ pretreatment psychosocial distress linked to patients’ pain interference during the first year of treatment. J Pain. 2024;25(7):104491. doi:10.1016/j.jpain.2024.02.005
26. Sreenivasan S, Fang C, Flood EM, Markuzon N, Sze JYY. Insights into the patient experience of hormone therapy for early breast cancer treatment using patient forum discussions and natural language processing. JCO Clin Cancer Inform. 2024;8:e2400038. doi:10.1200/cci.24.00038
27. Dias Nunes J, Demeestere I, Devos M. BRCA mutations and fertility preservation. Int J Mol Sci. 2023;25(1). doi:10.3390/ijms25010204
28. Chen X, Yan Q, Tang Y, Zhu J, Zhang W, Zhang J. Financial toxicity, family resilience and negative emotions among young and middle-aged breast cancer patients: a multicentre cross-sectional study. Breast. 2024;75:103735. doi:10.1016/j.breast.2024.103735
29. Yao H, Chan CHY, Chan CLW. Childbearing importance: a qualitative study of women with infertility in China. Res Nurs Health. 2018;41(1):69–77. doi:10.1002/nur.21846
30. Cao D, Bai C, Zhang G. Psychological distress among infertility patients: a network analysis. Front Psychol. 2022;13:906226. doi:10.3389/fpsyg.2022.906226
31. Loke AY, Yu PL, Hayter M. Experiences of sub-fertility among Chinese couples in Hong Kong: a qualitative study. J Clin Nurs. 2012;21(3–4):504–512. doi:10.1111/j.1365-2702.2010.03632.x
32. Bradford A, Woodard TL. Novel psychological intervention for decision support in women considering fertility preservation before cancer treatment. J Adolesc Young Adult Oncol. 2017;6(2):348–352. doi:10.1089/jayao.2016.0066
33. Dube L, Bright K, Hayden KA, Gordon JL. Efficacy of psychological interventions for mental health and pregnancy rates among individuals with infertility: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(1):71–94. doi:10.1093/humupd/dmac034
34. Huang Y, Huang Y, Bao M, Zheng S, Du T, Wu K. Psychological resilience of women after breast cancer surgery: a cross-sectional study of associated influencing factors. Psychol Health Med. 2019;24(7):866–878. doi:10.1080/13548506.2019.1574353
35. Dai Q, Liu X, Xu X, et al. Development of a supportive care framework for breast cancer survivor’s unmet needs: a modified Delphi study. J Clin Nurs. 2024;33(4):1376–1386. doi:10.1111/jocn.16963
36. Borgi M, Collacchi B, Ortona E, Cirulli F. Stress and coping in women with breast cancer: unravelling the mechanisms to improve resilience. Neurosci Biobehav Rev. 2020;119:406–421. doi:10.1016/j.neubiorev.2020.10.011
37. Uchino BN. Understanding the links between social support and physical health: a life-span perspective with emphasis on the separability of perceived and received support. Perspectives Psychol Sci. 2009;4(3):236–255. doi:10.1111/j.1745-6924.2009.01122.x
38. Bergqvist J, Strang P. Breast cancer patients’ preferences for truth versus hope are dynamic and change during late lines of palliative chemotherapy. J Pain Sympt Manage. 2019;57(4):746–752. doi:10.1016/j.jpainsymman.2018.12.336
39. Chan CH, Chan CL, Ng EH, et al. Incorporating spirituality in psychosocial group intervention for women undergoing in vitro fertilization: a prospective randomized controlled study. Psychol Psychother. 2012;85(4):356–373. doi:10.1111/j.2044-8341.2011.02040.x
40. Chen Q, Zhang P, Kejin W. Clinical Practice Guide for fertility preservation in female breast cancer patients of childbearing age in China. Chin J Pract Sur. 2023;43(02):136–138. doi:10.19538/j.cjps.issn1005-2208.2023.02.03
41. Tomasi-Cont N, Lambertini M, Hulsbosch S, Peccatori AF, Amant F. Strategies for fertility preservation in young early breast cancer patients. Breast. 2014;23(5):503–510. doi:10.1016/j.breast.2014.05.024
42. Lambertini M, Peccatori FA, Demeestere I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines(†). Ann Oncol. 2020;31(12):1664–1678. doi:10.1016/j.annonc.2020.09.006
43. Paluch-Shimon S, Cardoso F, Partridge AH, et al. ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5). Ann Oncol. 2022;33(11):1097–1118. doi:10.1016/j.annonc.2022.07.007
44. Cardoso F, Paluch-Shimon S, Schumacher-Wulf E, et al. 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). Breast. 2024;76:103756. doi:10.1016/j.breast.2024.103756
45. Ehrbar V, Urech C, Rochlitz C, et al. Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation. Hum Reprod. 2019;34(9):1726–1734. doi:10.1093/humrep/dez136
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles


The Development of Schematics to Illustrate Women’s Experiences with Adjuvant Hormone Therapy in the Treatment of Breast Cancer
AlOmeir O, Patel N, Donyai P
Patient Preference and Adherence 2022, 16:2639-2647
Published Date: 23 September 2022


Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand
Yeo HY, Wong JHY, Chan SJ, Latu ATF, Han CH, Anwar M, Marra CA
Patient Preference and Adherence 2023, 17:3525-3537
Published Date: 22 December 2023
A Qualitative Study on the Experience of Assisted Reproductive Technology in Women with Dyspareunia
Wei Q, Wang Z, He Y, Hong X, Shen X, Zhang S
International Journal of Women's Health 2024, 16:543-553
Published Date: 26 March 2024
What are the Thoughts of Women Whose Husbands’ Frozen Testicular Sperm Is Thawed for in vitro Fertilization on the Day of Oocyte Retrieval? A Qualitative Study
He Y, Wei Q, Chen X, Zhang C, Wang Z
International Journal of Women's Health 2025, 17:87-98
Published Date: 20 January 2025
Perspectives of People with Type 2 Diabetes Mellitus Towards a Decision Aid Assessing Preferences of Glucose-Lowering Drugs: The Dilemma of Choosing
Roldan Munoz S, Mol PGM, de Vries F, van Dijk PR, Hillege H, Postmus D, de Vries ST
Patient Preference and Adherence 2025, 19:215-234
Published Date: 25 January 2025